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Abstract
The goiter was described in history for long time. Many luminaries suffered from 
it. The enlargement of thyroid is known as goiter, it can arise from various causes 
and each has separate aetiopathogenesis and treatment. As an overview for the book, 
this chapter delves into each aspect, whereas the details are in separate chapter.
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1. Introduction
Thyroid gland is a butterfly shaped organ lying in the anterior aspect of the 
neck. The major function of the gland is the production of thyroid hormones, 
namely Triiodothyronine and Tetraiodothyronine. These hormones are the major 
regulators of the various metabolic processes in the human body.
Various pathological processes affect the organ. One of the clinical manifestations 
of these pathological processes is enlargement of the gland. In general the abnormal 
enlargement of thyroid gland is defined as goiter by American thyroid association [1].
Historically goiter was mentioned in literature of various languages around the 
world. Ancient Indian physicians have described the condition called as Galaganda in 
detail in Ayurveda books written between fourteenth century BC and 400 A.D [2]. 
Many sculptures and paintings around the world have goiter being depicted suggest the 
prevalence of knowledge regarding goiter among the common people during those ages.
During 1600 BC Chinese used to treat the condition with the sea weed [3]. Even 
though ancient doctors use to treat the condition with sea weed, the exact pharma-
cological basis behind this treatment was understood only after the discovery of 
Iodine by Bernard Courtois in 1811 [4].
Association of iodine deficiency with goiter was first discovered during 19th 
century by various researchers like Lugol (1786–1851) and Coindet (1774–1834). But 
it was in the David Marine who proved requirement of iodine for normal thyroid 
function in a trial conducted between 1917 and 1922 in Ohio [5]. In 1835 Case of 
goiter with exophthalmos were described by Robert James Graves [6]. Thyroid 
hormone in pure form was extracted by Edward Kendall in 1914 at Mayo clinic [7].
Major progress occurred during twentieth century in management of Graves’ 
disease with development of different treatment modalities like radioactive iodine 
and thionamides. Twenty-first century was marked with development of safer 
surgical practices and in depth understanding of the goiter pathology leading to 
better management of the condition.
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2. Anatomy and embryology of thyroid gland
Thyroid gland is located anteriorly in lower neck and extending between C5 to 
T1 vertebrae. A normal adult thyroid gland is approximately 40–60 mm longitu-
dinal and 13–18 mm AP diameter in size [8]. Mean ultrasound volume is around 
7–10 ml and weighing of 9–21 g.
Microscopically the gland is divided into lobes and lobules. Lobules are further 
subdivided into follicles. These follicles are made up of principal (follicular) cells 
which are a type of epithelial cell. These cells produce colloid (iodo-thyroglobulin).
Other types of epithelial cells seen in gland are parafollicular cells (c cell) which 
lie adjacent to follicles. C cell produce calcitonin.
Thyroid gland development starts by third to fourth week of gestation and 
originates from primitive pharynx and the neural crest cells. The development begins 
as a diverticulum at the dorsum of tongue. This diverticulum forms hypoglossal duct 
which passes from foramen caecum to infrahyoid region. The supra hyoid part of thy-
roglossal duct degenerates whereas the infra hyoid part develops into thyroid gland.
The gland is supplied by superior thyroid artery, inferior thyroid artery and thyroi-
dea ima. Venous drainage is provided by superior, middle and inferior thyroid vein.
The lymphatic drainage courses to prelaryngeal, pretracheal and paratracheal 
lymph node.
3. Classification of goiter
Goiter can be classified based on anatomically, etiologically, pathophysiologic 
ally and functionally (Table 1 and Figure 1).
3.1 Dyshormonogenesis
Autosomal recessive disorders (exception DUOX 2 mutation). Enzymatic defect 
in one of the steps of thyroid hormone synthesis. The most common cause being the 
deficiency of thyroid peroxidase enzyme. Prevalence is more among females.
Anatomical classification of goiter
Cervical goiter
Retrosternal goiter
Intrathoracic goiter
Functional classification
Toxic goiter
Non-toxic goiter
• Euthyroidism
• Hypothyroidism
Morphological classification
Diffuse goiter
Nodular goiter
• Solitary nodular goiter
• Multinodular goiter
Table 1. 
Anatomical, functional and morphological classification of goiter.
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Most of the cases present clinically before third decade with as earliest as in 
neonatal period with goiter and hypothyroidism. In Pendred syndrome dyshor-
monogenetic goiter is associated with deafness.
3.2 Dietary factors
3.2.1 Iodine deficiency
Twenty-nine percent of world population lives in area where soil is deficient 
in iodine, e.g., the Himalayan region in India. The most common cause of goiter 
worldwide is iodine deficiency. More than 30% of population having median 
urine iodine less than 20 mcg/l developed goiter [9]. Daily requirement of  
iodine is 100–150 mcg/day, but the requirement increases in pregnant and lactat-
ing women.
3.2.2 Dietary goitrogens
Soy and Millet contains flavonoids which impair thyroid peroxidase activity. 
Cyanogenic glucosides in Cassava, Lima beans compete for iodine uptake in thyroid 
follicles. Similarly cruciferous vegetables like cabbage cauliflower, broccoli contains 
glucosinolates which also competes with thyroidal iodine uptake.
3.3 Drugs causing goiter
Drugs like Lithium, Amiodarone apart from Antithyroid drugs are known 
to cause goiter. Rare causes include Interferon Alfa, Rifampicin, Phenytoin, and 
Phenobarbitone.
3.4 Hashimotos thyroiditis
The condition is named after Japanese physician Hakaru Hashimoto. This 
autoimmune thyroid disorder is characterized by diffuse lymphocytic infiltration of 
thyroid gland along with follicular destruction. Serologically the patients have high 
titer of anti-thyroglobulin and anti TPO antibodies. Hashimoto’s thyroiditis is the 
next most common cause of hypothyroidism after iodine deficiency. But subset of 
patient may remain clinically and biochemically euthyroid for rest of the life. The 
condition has female to male prevalence ratio of 7:1.
Figure 1. 
Classification of goiter on the basis of pathophysiology.
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3.5 Multinodular goiter
David Marine and Selwyn Taylor proposed that chronic intermittent stimu-
lus leads to variable thyroid hyperplasia resulting in multinodular goiter [10]. 
Various factors including genetic heterogeneity of follicular cells, secondary 
elevation of TSH due to iodine deficiency, goitrogens, and inborn error of thy-
roid hormone synthesis are considered to be factors involved in pathogenesis of 
condition.
3.6 Infiltrative thyroid disorder
Various infiltrative disorders like amyloidosis, histiocytosis, cystinosis and 
sarcoidosis may affect thyroid gland.
3.7 Graves’ disease
This autoimmune condition is characterized by presence of TRAB (TSH recep-
tor autoantibodies) in the serum. The clinical feature ranges from hyperthyroidism, 
orbitopathy, dermopathy and goiter.
3.8 Thyroid adenoma
These are benign tumors, classified as either follicular (most common form) 
or papillary (rare) type. Adenomas may be hyper functioning when they are 
termed toxic adenoma. Follicular adenoma are histopathologically divided 
into Fetal (micro follicular), Colloid (macro follicular), Embryonal (atypical), 
Hurthle cell adenoma (oxyphil or oncocytic tumor) types. Among these with the 
exception of colloid type all other histopathological types have potential for micro 
invasion.
3.9 Thyroid malignancies
Thyroid malignancies are classified as papillary carcinoma (most common 
type), follicular carcinoma, medullary thyroid carcinoma, anaplastic carcinoma, 
thyroid lymphoma (rare) clinical features are explained below.
4. Pathophysiology of goiter
Thyroid stimulating hormone is the major trophic factor for thyroid gland. TSH 
acts on TSH receptors present on thyroid cells which are G protein coupled recep-
tors. Downstream signaling leads to gene transcription leading to cell proliferation 
and differentiation (Figure 2).
The most common condition causing TSH dependent Goiter is iodine 
deficiency.
Goiter in chronic Hashimoto’s thyroiditis is also secondary to elevated TSH 
levels.
In conditions like Graves’ disease TSH receptors are stimulated by TSH stimulat-
ing antibodies Infection and neoplasia are examples for non-humoral causes of 
thyroid enlargement. Neoplastic enlargement occurs secondary to clonal expansion 
are usually are associated with underlying genetic alterations.
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5. Differential diagnosis of swelling in anterior aspect of neck
5.1 Approach to patient with goiter
5.1.1 History and examination
Extensive history should be taken in all patients with goiter (Table 2).
Following points should be highlighted while taking history like place of resi-
dence (patients from high altitude areas iodine deficient), dietary iodine intake, 
family history of thyroid disorders, radiation exposure and any history of goitro-
genic drugs intake.
Figure 2. 
TSH signaling pathway.
1. Goiter
2. Neurogenic tumors
3. Thymoma
4. Bronchogenic cysts
5. Pericardial cysts
6. Lymphoma
7. Teratoma
8. Thyroglossal cyst
Table 2. 
Differential diagnosis of swelling in anterior aspect of neck.
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Major concern of nodular thyroid disorder is development of malignancy. Hence 
history regarding risk factors for malignancy like age (<20 and >60 years), male 
sex, previous radiation exposure, family history of thyroid malignancy, MEN 2A 
syndrome should be obtained.
5.2 Clinical evaluation
5.2.1 Physical examination
The thyroid examination is done with patient in sitting or standing position. 
Goiter is classified according to World Health Organization (WHO) classification 
[11] (Table 3).
Thyroid gland is palpated from behind the patient with neck relaxed and looked 
for size, consistency, nodules, and tenderness and lymphadenopathy.
Consistency of the enlarged gland helps in making diagnosis. Lesions which are 
hard for palpation suggest malignancy but rarely Reidel’s thyroiditis may present 
like this. The gland feels rubbery in Hashimoto’s thyroiditis. Diffuse tenderness can 
be elicited in sub-acute Thyroiditis.
Palpable thrill and hearing of bruit during auscultation over the gland suggest 
hypervacularity, it is seen in condition like Graves’ disease.
During local examination one should look for lymphadenopathy and following 
group of lymph nodes should be examined (1) supraclavicular nodes, (2) anterior 
cervical chain lymph nodes, (3) posterior cervical chain lymph nodes, and (4) sub-
mental lymph nodes.
5.2.1.1 Pemberton’s maneuver
The patient is advised to rise both the arm till they touch the face on respective 
sides. The test is considered positive if patient develops facial plethora. Thyroid 
gland obstructing thoracic inlet which lead to venous obstruction is considered to 
be the underlying mechanism.
Grade 0: No goiter is palpable or visible.
Grade 1: Palpable goiter, not visible when neck is held in normal position
Grade 2: A clearly swollen neck (also visible in normal position of the neck) that is consistent with a goiter on 
palpation
Table 3. 
WHO classification of goiter.
Increased sweating Onycholysis
Hyperpigmentation Thinning of the hair
Systolic hypertension Increase appetite
Weight loss Palpitation
Heat intolerance Insomnia
Hyper defecation Menstrual irregularity oligo-/hypomenorrhea
Eye: lid retraction, lid lag, exophthalmos, ophthalmoplegia
Table 4. 
Symptoms and signs of hyperthyroidism.
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General examination includes looking signs of hyperthyroidism, hypothyroidism 
and metastatic involvement of different organs in suspected thyroid malignancy.
Signs and symptoms of hyperthyroidism and hypothyroidism are enlisted in 
Tables 4 and 5 respectively.
Symptoms of thyroid malignancy: Most commonly manifest as solitary nodule 
which are usually painless in nature. Malignant conversion of thyroid nodules is 
more common among males than females. Hoarseness of voice and dysphagia sug-
gest local involvement of recurrent laryngeal nerve and digestive tract.
Malignant nodules on palpation range from soft to hard consistency. Regional 
lymphadenopathy suggests lymph node metastasis.
5.2.2 Investigation
5.2.2.1 Thyroid function test
Thyroid function test is evaluated starting with measurement of measure-
ment of serum TSH level. If TSH level are less than normal values then next step 
is to measure T3 and. Normal T3 and T4 level (total T4: 4.5–12.5 μg/dL, free T4: 
0.8–1.7 ng/dL, total T3:0.8–2.0 ng/ml, free T3: 2.3–4.2 pg./mL) suggest subclinical 
hyperthyroidism whereas elevated T3 and T4 level suggest overt hyperthyroidism. 
Both overt and subclinical hyperthyroidism suggest Graves’ disease or toxic MNG.
If TSH levels are less than normal value then next step is to measure T4 level. 
Subclinical hypothyroidism is considered when value of TSH levels between 5 and 
10  μ U/ml with normal T4 level. Iodine deficiency and Hashimoto’s thyroiditis are 
the most common cause of subclinical or overt hypothyroidism.
5.2.2.2 Thyroid peroxidase antibodies
Presence of the antibody in serum suggest autoimmune thyroid disorder
5.2.2.3 Thyroid ultrasound
Even though all patients with enlarged thyroid gland requires sonographic assess-
ment to rule out malignancy, risk decreases in patients having TSH below normal or 
in low normal range. There are certain indications which make ultrasound assessment 
General
• Lethargy
• Somnolence
• Weight gain
• Cold Intolerance
Cardiovascular
• Bradycardia
• Angina
• Congestive heart failure
• Pericardial Effusion
Hematological
• Anemia
Dermatological
• Dry flaky skin and hair
• Myxedema
• Malar flushes
• Vitiligo
• Carotenemia
Gastro-intestinal
• Constipation
• Ileus
• Ascites
Reproductive system
• Infertility
• Menorrhagia
Neuromuscular
• Aches and pains
• Muscle stiffness
• Carpel tunnel syndrome
• Hoarseness
• Cerebellar ataxia
• Delayed deep tendon reflex
• Myotonia
• Depression
• Psychosis
Table 5. 
Signs and symptoms of hypothyroidism.
Goiter - Causes and Treatment
8
mandatory like palpable solitary nodule, palpable multinodular goiter, and suspicion 
of nodule in patient with difficult neck palpation, rapid growth of a goiter, thyroid 
asymmetry, firm consistency, tenderness, normal TSH and negative TPO antibodies.
5.2.2.4 Fine-needle aspiration cytology
Indications for FNAC include rapid growth of the swelling which suggest malig-
nant transformation, signs of inflammation (abscess formation) and nodules with 
indeterminate or suspicious features (ultrasound proven).
5.2.2.5 Computed tomography of neck
Computed tomography of neck not usually advised is required rarely to assess 
the extension of large cervical goiters and sub sternal goiters.
5.2.2.6 Technetium-99 m (99mTc) thyroid scans/radioiodine uptake scans
Routine use of thyroid scintigraphy is not indicated in the assessment of goiter. 
A hot area in scintigraphy suggest benign lesion which can be of help to rule out 
malignant lesions when FNAC report of the thyroid nodules are equivocal. When 
TSH level is low and clinical features are suggestive of hyperthyroidism techne-
tium-99 scan/Radio iodine uptake scan are useful to differentiate between Graves’ 
disease, thyroiditis and toxic adenoma.
6. Treatment
Treatment of goiter depends on whether TSH levels are normal or abnormal.
If TSH is elevated than normal, Levothyroxine supplementation is given for 
patient with overt hypothyroidism starting with a dose of 1.6 mcg/kg body weight 
per day in non-pregnant adults.
There are certain Indications for treatment of subclinical hypothyroidism like Anti-
TPO positivity, menstrual irregularity, infertility, chronic kidney disease, pregnancy.
If TSH is less than normal range then the treatment modality depends on the nature 
of the illness in Graves’ disease we have got three effective treatment modalities, i.e., 
thionamides (anti-thyroid drugs), radioiodine or surgery. Starting dose of Methimazole 
ranges from 10 to 40 mg per day in divided doses initially followed by single daily dose-
Beta blockers are used for relief of tachycardia in non-asthmatic patients.
In multinodular goiter and toxic adenoma treatment modality is either radioio-
dine ablation surgery.
Iodine radioisotope I-131 is usually used for radioiodine ablation. It takes 
6–18 weeks for thyroid tissue ablation post radioiodine administration. Treatment 
of subclinical hyperthyroidism is considered in patient older than age of 65 years 
and patient with other comorbidities like heart disease, osteoporosis, and post-
menopausal women not on HRT.
Surgery is indicated in patients with large goiters with compressive symptoms, 
malignancy, and failed medical therapy.
7. Conclusions
The goiter is a known disorder affecting females more than males. It has vari-
ous etiologies classified depending on the levels of TSH. The treatment of goiter is 
according to the etiology.
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